Positive opinion from the CHMP for TRECONDI® (treosulfan) by medac for toxicity-reducing conditioning for allogeneic haematopoietic stem cell transplantation. Further information can be found by clicking here
Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in […]
Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Innovative therapeutic for the treatment of mild actinic keratoses – first self-adhesive patch for PDT The skin lesion actinic keratosis is associated with an estimated prevalence of up to 60 % in certain populations and bears a high disease burden being considered as precancerous The treatment option with the ALA-PDT patch has not only been […]
medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]